CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1227874-1228097
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"On the other hand, patients harboring antibodies to membranous antigens like voltage gated potassium channels (or associated proteins) or NMDARs seem to have disorders pathogenetically linked to those antibodies themselves.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T37073","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T37073","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T2675","span":{"begin":0,"end":223},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T2675","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T275","span":{"begin":0,"end":223},"obj":"Sentence"}],"attributes":[{"subj":"T275","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T5018","span":{"begin":13,"end":17},"obj":"Body_part"}],"attributes":[{"id":"A5018","pred":"uberon_id","subj":"T5018","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"},{"subj":"T5018","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecaa","default":true},{"id":"Epistemic_Statements","color":"#ec9395"},{"id":"CORD-19_Custom_license_subset","color":"#93afec"},{"id":"CORD-19-PD-UBERON","color":"#caec93"}]}]}}